Erythema multiforme-like bullous pemphigoid following COVID-19 mRNA
vaccine
- Azza Ghannem
, - Faten Rabhi,
- Faten Gargouri,
- Kahena Jaber,
- Raouf Dhaoui
Abstract
Cases of bullous pemphigoid following Covid-19 vaccines have been
recently reported. We describe herein an atypical case of acral bullous
pemphigoid after Pfizer BionTech vaccine. Clinicians should be aware of
this reaction and encourage full vaccination as the disease displays a
rapid improvement treatment.02 Oct 2022Submitted to Clinical Case Reports 11 Oct 2022Assigned to Editor
11 Oct 2022Submission Checks Completed
16 Oct 2022Reviewer(s) Assigned
11 Dec 2022Review(s) Completed, Editorial Evaluation Pending
15 Mar 2023Editorial Decision: Revise Minor
